(Q45156479)

10 December 2017

The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients (English)

1 reference

10 December 2017

0 references

Erkan Coban

1

1 reference

PubMed ID

15554350

10 December 2017

Ramazan Sari

series ordinal

2

1 reference

10 December 2017

1 August 2004

1 reference

10 December 2017

1 reference

10 December 2017

30

1 reference

10 December 2017

3

1 reference

10 December 2017

343-349

1 reference

High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment

10 December 2017

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Obesity-induced inflammatory changes in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Inflammatory bio-markers and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Fibrates, dyslipoproteinaemia and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Effect of ciprofibrate on C-reactive protein and fibrinogen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Effects of fibrates on serum metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Peroxisome proliferator-activated receptors and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200033541

21 January 2018

Identifiers

DOI

10.1081/ERC-200033541

1 reference

10 December 2017

1 reference

PubMed ID

15554350